Sandalwood Oil and Turmeric-Based Cream Prevents Ionizing Radiation-Induced Dermatitis in Breast Cancer Patients: Clinical Study

• Published in: Medicines (Basel, Switzerland) Vol. 4; no. 3; p. 43
• Main Authors: Rao, Suresh, Hegde, Sanath Kumar, Baliga-Rao, Manjeshwar Poonam, Lobo, Jyothi, Palatty, Princy Louis, George, Thomas, Baliga, Manjeshwar Shrinath
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 24.06.2017; MDPI AG
• Subjects: breast cancer; radiation; radiodermatitis; Vicco turmeric; breast cancer; Vicco turmeric; radiation; radiodermatitis
• ISSN: 2305-6320; 2305-6320
• DOI: 10.3390/medicines4030043

: The primary objective of this study was to ascertain the benefit of Vicco turmeric Ayurvedic cream (VTC; Vicco Laboratories, Mumbai, India) sandalwood oil and turmeric-based cream in preventing radiodermatitis in women undergoing curative radiotherapy for their breast cancer. : The study was an investigator-blinded randomized study with Johnsons Baby Oil (JBO; Johnson & Johnson Ltd., Baddi, India) as a comparator, administered daily from the start of radiation therapy for 5 weeks in women receiving breast radiation therapy, 50 Gy in 2 Gy fractions daily for 5 weeks. The endpoints were to ascertain the delay in the appearance and the degree of severity of dermatitis throughout the study period in accordance to the Therapy Oncology Group (RTOG) score. : The results indicated that the topical application of VTC delayed and mitigated the radiodermatitis. When compared to the Johnson's Baby Oil, a significant decrease ( = 0.025) in the incidence of grade 1 was seen at week two, and also in grade 2 and 3 at week 3 ( = 0.003) and week 4 ( = 0.02), respectively, in the VTC cohort. A concomitant decrease in the average severity was also observed at week 2 ( = 0.02), week 3 ( = 0.05) and week 4 ( = 0.03). The results indicate that VTC cream significantly reduces radiation dermatitis when applied to the breast during and after radiation therapy. The result of this study indicates the beneficial effects. Double blind randomized control studies are required to further confirm the beneficial effects of VTC in mitigating radiodermatitis is people undergoing radiation treatment for their cancer.